|
|
||||||||
Ann Thorac Surg 2000;69:337-343
© 2000 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Address reprint requests to Dr Walsh, Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Box 109, 1515 Holcombe Blvd, Houston, TX 77030
Presented at the Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 2527, 1999.
Background. Primary nonseminomatous germ cell tumors of the mediastinum (PNSGM), unlike malignancies of gonadal origin, have a poor prognosis. We report a single institutional experience over a 5-year period of PNSGM treated with intensive chemotherapy, followed by radical operation in those who responded to this neoadjuvant regimen.
Methods. From 1993 to 1998, 20 patients were referred for the management of PNSGM. All were male, with a median age of 30.5 years (range 18 to 48). Eighteen of 20 (90%) presented with symptoms. Most tumors were large, with a median diameter of 10 cm (range 3 to 20 cm). Thirteen patients (65%) had metastatic disease at the time of presentation. Eleven patients had received no prior treatment (initial group) and 9 were referred for salvage therapy after progression of their tumors, following treatment at other facilities (salvage group). All had elevated serum tumor markers (ßhCG and
-fetoprotein). Preoperative chemotherapy included alternating cycles of combinations of 3 or more drugs, including cisplatin, bleomycin, etoposide, vincristine, methotrexate, actinomycin, cyclophosphamide, and doxorubicin. An average of 10 cycles of chemotherapy was given to each patient in the initial group, and six to those in the salvage group. Five patients (25%) developed transient renal insufficiency, and 35% developed pulmonary infiltrates related to bleomycin. There were 3 chemotherapy related deaths.
Results. After chemotherapy, 11 patients underwent operation, with 10 complete resections of the residual mediastinal tumors. There were no perioperative deaths. The 2-year survival in the initial group is 72%, and 42% for the salvage group.
Conclusions. An aggressive, multidisciplinary approach of alternating cycles of chemotherapy, followed by complete surgical resection of all remaining disease in patients whose markers normalize, can be associated with prolonged survival in patients with PNSGM.
Related Article
Ann. Thorac. Surg. 2000 69: 343-344.
This article has been cited by other articles:
![]() |
K. A. Kesler, K. M. Rieger, Z. T. Hammoud, L. E. Kruter, S. M. Perkins, M. W. Turrentine, B. P. Schneider, L. H. Einhorn, and J. W. Brown A 25-Year Single Institution Experience With Surgery for Primary Mediastinal Nonseminomatous Germ Cell Tumors Ann. Thorac. Surg., February 1, 2008; 85(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Kang, Y. T. Kim, S.-H. Jheon, S.-w. Sung, and J. H. Kim Surgical Treatment of Malignant Mediastinal Nonseminomatous Germ Cell Tumor Ann. Thorac. Surg., February 1, 2008; 85(2): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Date, K. Kiura, H. Ueoka, M. Tabata, K. Hotta, H. Katayama, I. Kataoka, and M. Tanimoto Induction chemotherapy, surgical resection, and high-dose chemotherapy for mediastinal nonseminomatous germ-cell tumor J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1205 - 1206. [Full Text] [PDF] |
||||
![]() |
B. V. Duwe, D. H. Sterman, and A. I. Musani Tumors of the Mediastinum Chest, October 1, 2005; 128(4): 2893 - 2909. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakurai, H. Asamura, K. Suzuki, S.-i. Watanabe, and R. Tsuchiya Management of Primary Malignant Germ Cell Tumor of the Mediastinum Jpn. J. Clin. Oncol., July 1, 2004; 34(7): 386 - 392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |